0
2022
Diabetic Retinopathy Market

Diabetic Retinopathy Market

by Type (Proliferative Diabetic Retinopathy, Diabetic Macular Edema (DME)), and Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy): Global Opportunity Analysis and Industry Forecast, 2020-2030

✷  Report Code: A01680
Pages: 157
Feb 2022 | 13457 Views
Author(s) : Vishal Bhardwaj, Ajinkya Alhat , Onkar Sumant
Tables: 56
Charts: 53
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Diabetic Retinopathy Market

Request Now !

Diabetic Retinopathy Market Overview 2030:

The global diabetic retinopathy market size was valued at $3,086.00 million in 2020, and is projected to reach $10,785.50 million by 2030, registering a CAGR of 13.7% from 2021 to 2030. Diabetic retinopathy (DR) is an eye disease associated with diabetic patients. The disease occurs when there is damage to the retina due to diabetes. Without timely treatment, the disease may lead to bleeding in the eyes, cloudy vision, and may even destroy the retina. DR is among the common cause of loss of vision in the diabetic population; eventually leading to blindness.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global diabetic retinopathy market. The outbreak of COVID-19 has disrupted workflows in the healthcare sector globally. Ophthalmic outpatient visits were broadly reduced to urgent and emergent cases only, and the procedures along with operations were postponed and the transition to tele-ophthalmology visits was limited, as ophthalmological care is heavily dependent on specialized imaging equipment that is not readily available outside of ophthalmologists’ offices which is hampering the market growth.

At first, diabetic retinopathy might cause no symptoms or only mild vision problems. However, it can lead to blindness. The condition can develop in anyone who has type 1 or type 2 diabetes. The longer a person has diabetes with less controlled blood sugar can lead to eye complication. Diabetic retinopathy can lead to other serious eye conditions such as diabetic macular edema, retinal detachment, and neovascular glaucoma.

Diabetic-Retinopathy-Market

Increase in prevalence of diabetes, rise in geriatric population, growth in incidence of blindness due to diabetes, and augment of focus on awareness that facilitates early diagnosis to control the diseases drive the market. However, this growth is limited by dearth of skilled ophthalmologists, and extended approval time for drugs. Conversely, emergence of combined therapies for treatment of diabetic macular edema and the emerging markets of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for diabetic retinopathy market growth during the forecast period.

Impact Of Covid-19 On Diabetic Retinopathy Market (Pre And Post Analysis)

The outbreak of COVID-19 has disrupted workflows in the healthcare sector globally. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. The overall impact of the COVID-19 pandemic was negative for key players in the Diabetic Retinopathy market. The COVID-19 pandemic led to disruptions in the healthcare facilities. Ophthalmic outpatient visits were broadly reduced to urgent and emergent cases only, and the procedures along with operations were postponed. There has been a decline of 81% in the ophthalmology clinic visits in March and April 2020 compared to the same period in 2019 as the patients avoided hospital visits. Retina clinics experienced about a 71% volume loss. Unlike other specialties, the transition to tele-ophthalmology visits was limited, as ophthalmological care is heavily dependent on specialized imaging equipment that is not readily available outside of ophthalmologists’ offices. DR screening was also frequently postponed during the pandemic, particularly in areas with high COVID-19 community transmission. For example, at the Wilmer Eye Institute, diabetic eye exams decreased from 1,145 visits in the 6 weeks prior to pandemic-related clinical practice changes to just 59 in the first 6 weeks after these changes were implemented.

Diabetic Retinopathy Market Segmentation

The diabetic retinopathy market in this report is studied on the basis of type, treatment type, and region. On the basis of type, the market is divided by proliferative diabetic retinopathy, and diabetic macular edema (DME). By treatment type, the market is classified into anti VEGF drug, steroid implants, laser surgeries, and vitrectomy. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Diabetic Retinopathy Market
By Type

Your browser does not support the canvas element.

Proliferative diabetic retinopathy segment held a dominant position in 2020.

Get more information on this report : Request Sample Pages

Segment Review

On the basis of type, the proliferative diabetic retinopathy segment currently dominates the global diabetic retinopathy market and is expected to continue during the forecast period owing to increasing prevalence of the medical condition worldwide. Globally, in 2017, among adults aged 45 and over with diagnosed diabetes, 32.2% had cataracts, 8.6% had diabetic retinopathy, 7.1% had glaucoma, and 4.3% had macular degeneration. This can serve as a major opportunity for manufacturers to capitalize and expand their market share.

On the basis of treatment type, the treatment type, the laser surgeries segment dominated the global diabetic retinopathy market in 2020 and is anticipated to be dominant in the market. Since this treatment type has been available in the market for a long period, there is high acceptance and familiarity with the procedure. Thus, laser surgeries serve to be the lucrative investment pocket.

Diabetic Retinopathy Market
By Treatment Type

Your browser does not support the canvas element.

Neurosurgery Navigation Systems segment held a dominant position in 2020.

Get more information on this report : Request Sample Pages

Region Segment Review

Region wise, North America dominated the market in 2020, owing to high prevalence of DR in this region, coupled with well-established infrastructure and increasing initiatives by the government to create awareness that would help people undergo screening for DR. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to rise in population base, high disposable incomes, and improvement in patient awareness about the treatment of diabetic retinopathy.

The major companies profiled in this report include Alimera Science, Inc., Abbvie, Inc., Ampio Pharmaceuticals, Inc., Bayer AG, Kowa Co., Ltd., Novartis, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., F-Hoffmann-La Roche Ltd, Valeant Pharmaceuticals International, Inc. (Bausch Health Companies Inc.).

Diabetic Retinopathy Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the fastest CAGR of 14.4% during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global diabetic retinopathy market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the diabetic retinopathy market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing diabetic retinopathy market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of diabetic retinopathy used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the diabetic retinopathy market.

Diabetic Retinopathy Market Report Highlights

Aspects Details
By Type
  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema (DME)
By Treatment Type
  • Anti VEGF Drug
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
List of key players profiled in the report:
  • Alimera Science, Inc.
  • Abbvie, Inc.
  • Ampio Pharmaceuticals, Inc.
  • Bayer AG
  • Kowa Co., Ltd.
  • Novartis
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • F-Hoffmann-La Roche Ltd.
  • Valeant Pharmaceuticals International, Inc. (Bausch Health Companies Inc.)
 

Loading Table Of Content...


 
 

According to the analyst’s perspective, globally, the use of therapeutics for the treatment of diabetic retinopathy is expected to increase in the near future, owing to high prevalence of diabetes coupled with rise in geriatric population. There are significant advancements in diabetic retinopathy treatment therapies for disease management. Asia-Pacific and LAMEA are expected to offer lucrative opportunities to market players due to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of diabetic retinopathy.

Increase in the prevalence of diabetes, the geriatric population, the incidence of blindness due to diabetes, and the focus on awareness, which facilitates early diagnosis to control the diseases drive the market growth. However, this growth is restricted by dearth of skilled ophthalmologists and extended approval time for drugs. Conversely, emergence of combined therapies for treatment of diabetic macular edema and the emerging markets of Asia-Pacific and LAMEA are expected to provide several opportunities for market growth during the forecast period.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Diabetic retinopathy (DR) is an eye disease associated with diabetic patients. The disease occurs when there is damage to the retina due to diabetes.

A. The total market value of Global Diabetic Retinopathy Market is $3,086.00 million in 2020.

A. The forecast period for Global Diabetic Retinopathy Market is 2021 to 2030.

A. The market value of Global Diabetic Retinopathy Market in 2030 is $10,785.50 million.

A. Abbvie, Inc., Bayer AG, Novartis, Pfizer, Inc., and F-Hoffmann-La Roche Ltd held a high market position owing to the strong geographical foothold in different regions.

A. Proliferative Diabetic Retinopathy segment dominates the global market, owing to increasing prevalence of the medical condition worldwide.

A. The major factor for the growth of global Diabetic Retinopathy market aregrowth in prevalence of diabetes, increased incidence of blindness due to diabetes, surge in geriatric population and raised awareness for treatment of diabetic retinopathy.

A. Owing to rise in the geriatric population in the market. Furthermore, rapidly increasing aging population and subsequent rise in the number of diabetic patients.

A. The base year is 2020 in Global Diabetic Retinopathy Market.

A. Diabetic Retinopathy treatment is used to treat the growth of new blood vessels at the back of the eye (retina) in cases of proliferative diabetic retinopathy, and to stabilise some cases of maculopathy.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Diabetic Retinopathy Market

Start reading instantly.
This Report and over 18,777+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers